Breast Cancer Therapeutics Market Report

China Breast Cancer Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 11, 2023
  • PAGES：183
  • REPORT CODE：GMM1791367
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Breast Cancer Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Puma Biotechnology

    • Syndax

    • BioMarin

    • Roche

    • MacroGenics

    • Halozyme Therapeutics

    • Janssen Biotech

    • Merck

    • Bayer HealthCare

    • Eli Lily

    • AbbVie

    • Pfizer

    • Novartis

    By Type:

    • Zoladex

    • HER2 Inhibitors

    • Mitotic Inhibitors

    • Aromatase Inhibitors

    • Anti-metabolites

    By Application:

    • Hospital

    • Others

    • Medical Research Laboratory

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Breast Cancer Therapeutics Market Overview 2018-2029

    • 1.1 China Breast Cancer Therapeutics Industry Development Overview

    • 1.2 China Breast Cancer Therapeutics Industry Development History

    • 1.3 China Breast Cancer Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Breast Cancer Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Zoladex (2018-2029)

      • 1.4.2 China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of HER2 Inhibitors (2018-2029)

      • 1.4.3 China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Mitotic Inhibitors (2018-2029)

      • 1.4.4 China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Aromatase Inhibitors (2018-2029)

      • 1.4.5 China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Anti-metabolites (2018-2029)

    • 1.5 China Breast Cancer Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Breast Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Breast Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Breast Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Medical Research Laboratory (2018-2029)

    • 1.6 China Breast Cancer Therapeutics Market Analysis by Region

      • 1.6.1 North China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Breast Cancer Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Breast Cancer Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Breast Cancer Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Breast Cancer Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Breast Cancer Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Breast Cancer Therapeutics Industry Development

    Chapter 3 Breast Cancer TherapeuticsIndustry Chain Analysis

    • 3.1 Breast Cancer Therapeutics Industry Chain

    • 3.2 Breast Cancer Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Breast Cancer Therapeutics Market

    • 3.3 Breast Cancer Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Breast Cancer Therapeutics Market

    Chapter 4 China Breast Cancer Therapeutics Market, by Type

    • 4.1 China Breast Cancer Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Breast Cancer Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Breast Cancer Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Breast Cancer Therapeutics Production Volume and Growth Rate of Zoladex

      • 4.5.2 China Breast Cancer Therapeutics Production Volume and Growth Rate of HER2 Inhibitors

      • 4.5.3 China Breast Cancer Therapeutics Production Volume and Growth Rate of Mitotic Inhibitors

      • 4.5.4 China Breast Cancer Therapeutics Production Volume and Growth Rate of Aromatase Inhibitors

      • 4.5.5 China Breast Cancer Therapeutics Production Volume and Growth Rate of Anti-metabolites

    Chapter 5 China Breast Cancer Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Breast Cancer Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Breast Cancer Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Breast Cancer Therapeutics Market Size and Growth Rate of Hospital

      • 5.5.2 China Breast Cancer Therapeutics Market Size and Growth Rate of Others

      • 5.5.3 China Breast Cancer Therapeutics Market Size and Growth Rate of Medical Research Laboratory

    Chapter 6 China Breast Cancer Therapeutics Market, by Region

    • 6.1 China Breast Cancer Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Breast Cancer Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Breast Cancer Therapeutics Market Analysis

    • 7.1 North China Breast Cancer Therapeutics Market, by Type

    • 7.2 North China Breast Cancer Therapeutics Market, by Application

    Chapter 8 Central China Breast Cancer Therapeutics Market Analysis

    • 8.1 Central China Breast Cancer Therapeutics Market, by Type

    • 8.2 Central China Breast Cancer Therapeutics Market, by Application

    Chapter 9 South China Breast Cancer Therapeutics Market Analysis

    • 9.1 South China Breast Cancer Therapeutics Market, by Type

    • 9.2 South China Breast Cancer Therapeutics Market, by Application

    Chapter 10 East China Breast Cancer Therapeutics Market Analysis

    • 10.1 East China Breast Cancer Therapeutics Market, by Type

    • 10.2 East China Breast Cancer Therapeutics Market, by Application

    Chapter 11 Northeast China Breast Cancer Therapeutics Market Analysis

    • 11.1 Northeast China Breast Cancer Therapeutics Market, by Type

    • 11.2 Northeast China Breast Cancer Therapeutics Market, by Application

    Chapter 12 Southwest China Breast Cancer Therapeutics Market Analysis

    • 12.1 Southwest China Breast Cancer Therapeutics Market, by Type

    • 12.2 Southwest China Breast Cancer Therapeutics Market, by Application

    Chapter 13 Northwest China Breast Cancer Therapeutics Market Analysis

    • 13.1 Northwest China Breast Cancer Therapeutics Market, by Type

    • 13.2 Northwest China Breast Cancer Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Puma Biotechnology

        • 14.1.1 Puma Biotechnology Company Profile

        • 14.1.2 Puma Biotechnology Breast Cancer Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Syndax

        • 14.2.1 Syndax Company Profile

        • 14.2.2 Syndax Breast Cancer Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 BioMarin

        • 14.3.1 BioMarin Company Profile

        • 14.3.2 BioMarin Breast Cancer Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Roche

        • 14.4.1 Roche Company Profile

        • 14.4.2 Roche Breast Cancer Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 MacroGenics

        • 14.5.1 MacroGenics Company Profile

        • 14.5.2 MacroGenics Breast Cancer Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Halozyme Therapeutics

        • 14.6.1 Halozyme Therapeutics Company Profile

        • 14.6.2 Halozyme Therapeutics Breast Cancer Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Janssen Biotech

        • 14.7.1 Janssen Biotech Company Profile

        • 14.7.2 Janssen Biotech Breast Cancer Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck

        • 14.8.1 Merck Company Profile

        • 14.8.2 Merck Breast Cancer Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Bayer HealthCare

        • 14.9.1 Bayer HealthCare Company Profile

        • 14.9.2 Bayer HealthCare Breast Cancer Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eli Lily

        • 14.10.1 Eli Lily Company Profile

        • 14.10.2 Eli Lily Breast Cancer Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AbbVie

        • 14.11.1 AbbVie Company Profile

        • 14.11.2 AbbVie Breast Cancer Therapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Pfizer

        • 14.12.1 Pfizer Company Profile

        • 14.12.2 Pfizer Breast Cancer Therapeutics Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Novartis

        • 14.13.1 Novartis Company Profile

        • 14.13.2 Novartis Breast Cancer Therapeutics Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Breast Cancer Therapeutics Industry Research Conclusions

    • 15.2 Breast Cancer Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Breast Cancer Therapeutics Industry Market Size (2018-2029)

    • Figure China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Zoladex (2018-2029)

    • Figure China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of HER2 Inhibitors (2018-2029)

    • Figure China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Mitotic Inhibitors (2018-2029)

    • Figure China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Aromatase Inhibitors (2018-2029)

    • Figure China Breast Cancer Therapeutics Production Volume, Production Value and Growth Rate of Anti-metabolites (2018-2029)

    • Figure China Breast Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Breast Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Breast Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Medical Research Laboratory (2018-2029)

    • Figure North China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Breast Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Breast Cancer Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Breast Cancer Therapeutics Market Share by Type in 2018

    • Figure China Breast Cancer Therapeutics Market Share by Type in 2023

    • Figure China Breast Cancer Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Volume and Growth Rate of Zoladex (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Volume and Growth Rate of HER2 Inhibitors (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Volume and Growth Rate of Mitotic Inhibitors (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Volume and Growth Rate of Aromatase Inhibitors (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Volume and Growth Rate of Anti-metabolites (2018-2023)

    • Figure China Breast Cancer Therapeutics Market Share by Application in 2018

    • Figure China Breast Cancer Therapeutics Market Share by Application in 2023

    • Figure China Breast Cancer Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Breast Cancer Therapeutics Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Breast Cancer Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Breast Cancer Therapeutics Market Size and Growth Rate of Medical Research Laboratory (2018-2023)

    • Table China Breast Cancer Therapeutics Production Volume by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Production Value by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Breast Cancer Therapeutics Production Value Share by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Sales Volume by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Breast Cancer Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Sales Value by Region (2018-2023)

    • Table China Breast Cancer Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Breast Cancer Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table North China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table South China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table East China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Breast Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Breast Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Breast Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Breast Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Puma Biotechnology Company Profile

    • Table Puma Biotechnology Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Syndax Company Profile

    • Table Syndax Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table BioMarin Company Profile

    • Table BioMarin Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table MacroGenics Company Profile

    • Table MacroGenics Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Halozyme Therapeutics Company Profile

    • Table Halozyme Therapeutics Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Janssen Biotech Company Profile

    • Table Janssen Biotech Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Company Profile

    • Table Bayer HealthCare Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Eli Lily Company Profile

    • Table Eli Lily Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Breast Cancer Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US